Divi's Laboratories Ltd
NSE:DIVISLAB

Watchlist Manager
Divi's Laboratories Ltd Logo
Divi's Laboratories Ltd
NSE:DIVISLAB
Watchlist
Price: 6 161.5 INR -0.11% Market Closed
Market Cap: ₹1.6T

Balance Sheet

Balance Sheet Decomposition
Divi's Laboratories Ltd

Balance Sheet
Divi's Laboratories Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2002 Mar-2003 Mar-2004 Mar-2005 Mar-2006 Mar-2007 Mar-2008 Mar-2009 Mar-2010 Mar-2011 Mar-2012 Mar-2013 Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
48
45
72
45
105
114
74
88
134
145
173
120
151
176
179
208
252
130
431
20 303
12 148
1 697
3 630
4 150
Cash
0
0
0
0
0
114
74
88
134
145
173
120
151
0
0
208
252
130
231
218
219
289
230
210
Cash Equivalents
48
45
72
45
105
0
0
0
0
0
0
0
0
176
179
0
0
0
200
20 085
11 929
1 408
3 400
3 940
Short-Term Investments
0
0
0
0
0
70
234
163
81
5 331
4 903
4 363
5 269
7 839
8 553
16 881
19 758
14 996
9 714
0
0
0
0
0
Total Receivables
583
698
967
1 281
1 595
1 921
2 487
3 100
2 596
4 078
5 464
5 652
7 579
7 761
9 109
9 393
11 333
12 965
16 812
11 696
12 730
20 372
23 950
30 060
Accounts Receivables
521
566
867
1 022
1 074
1 617
2 095
2 660
2 232
3 652
4 951
5 120
7 237
7 416
8 809
9 009
10 144
11 634
14 134
16 765
24 239
17 925
21 560
27 310
Other Receivables
62
132
100
259
521
304
392
440
364
426
513
532
342
345
300
384
1 189
1 331
2 678
5 069
11 509
2 446
2 390
2 750
Inventory
445
671
1 076
1 390
1 839
2 135
2 814
4 213
4 985
5 717
6 790
8 357
9 525
11 798
12 206
13 561
13 939
18 308
18 877
21 764
29 159
30 343
32 640
33 230
Other Current Assets
0
0
0
0
0
0
20
107
244
137
180
149
40
160
223
64
70
102
965
7 984
29 478
40 706
36 530
33 370
Total Current Assets
1 076
1 414
2 115
2 717
3 539
4 239
5 630
7 671
8 040
15 407
17 509
18 641
22 564
27 735
30 270
40 105
45 351
46 501
46 798
61 747
83 515
93 117
96 750
100 810
PP&E Net
973
1 510
1 718
1 826
2 912
4 189
5 569
6 094
6 136
6 937
9 200
12 121
13 663
15 231
16 998
19 995
21 094
25 756
36 979
44 095
47 875
49 292
55 130
64 600
PP&E Gross
973
1 510
1 718
1 826
2 912
4 189
5 569
6 094
6 136
0
9 200
12 121
13 663
0
16 998
19 995
21 094
25 756
36 979
44 095
47 875
49 292
55 130
64 600
Accumulated Depreciation
354
441
573
723
871
1 095
1 451
1 929
2 431
0
3 536
4 296
5 185
0
7 551
2 312
3 712
5 375
7 209
9 735
12 815
16 208
19 960
23 980
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
40
29
33
66
41
36
50
75
53
40
40
Note Receivable
0
0
0
0
0
0
0
0
0
361
852
624
564
424
1 546
1 137
1 308
2 586
1 494
1 106
1 102
198
1 280
2 470
Long-Term Investments
0
0
1
0
0
0
556
1 718
4 413
0
0
0
0
0
0
0
0
5 473
0
0
720
771
820
650
Other Long-Term Assets
2
0
0
0
40
7
33
65
72
43
5
1
314
400
178
316
40
26
50
743
461
957
680
750
Total Assets
2 052
N/A
2 925
+43%
3 834
+31%
4 543
+18%
6 491
+43%
8 436
+30%
11 787
+40%
15 548
+32%
18 660
+20%
22 748
+22%
27 567
+21%
31 388
+14%
37 105
+18%
43 829
+18%
49 021
+12%
61 585
+26%
67 859
+10%
80 383
+18%
85 357
+6%
107 741
+26%
133 747
+24%
144 388
+8%
154 700
+7%
169 320
+9%
Liabilities
Accounts Payable
343
520
530
676
841
884
1 254
1 465
1 503
1 230
1 595
1 604
1 517
2 269
2 327
4 458
4 112
4 923
5 907
7 632
7 957
7 625
8 240
9 100
Accrued Liabilities
0
1
0
0
3
0
3
1
1
0
501
580
722
807
1 077
1 111
1 068
1 700
1 782
2 381
3 074
2 380
2 230
2 750
Short-Term Debt
0
0
0
0
0
0
0
0
0
136
502
305
163
251
414
357
631
1 056
336
4
0
0
0
20
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
45
27
5
5
5
6
0
0
0
8
8
8
5
10
0
Other Current Liabilities
34
114
130
119
467
381
673
644
1 104
2 687
2 913
3 051
3 867
1 229
1 371
668
724
789
1 235
1 100
917
1 001
2 300
2 650
Total Current Liabilities
377
634
660
795
1 311
1 265
1 930
2 110
2 608
4 099
5 538
5 545
6 274
4 560
5 195
6 595
6 534
8 468
9 268
11 125
11 956
11 011
12 780
14 520
Long-Term Debt
452
434
659
661
1 502
1 540
861
526
328
49
26
21
16
11
5
0
0
0
45
37
29
28
20
20
Deferred Income Tax
156
178
223
250
279
277
383
497
546
500
609
792
1 150
965
773
1 264
1 927
2 212
2 740
3 381
4 214
5 372
5 820
5 090
Other Liabilities
0
0
0
0
0
0
0
0
0
124
79
24
32
70
116
153
150
132
205
253
267
306
370
0
Total Liabilities
985
N/A
1 246
+26%
1 542
+24%
1 706
+11%
3 092
+81%
3 081
0%
3 173
+3%
3 134
-1%
3 482
+11%
4 773
+37%
6 251
+31%
6 382
+2%
7 471
+17%
5 606
-25%
6 088
+9%
8 011
+32%
8 611
+7%
10 811
+26%
12 258
+13%
14 795
+21%
16 465
+11%
16 717
+2%
18 990
+14%
19 630
+3%
Equity
Common Stock
115
128
128
128
128
129
129
130
264
265
265
265
265
265
531
531
531
531
531
531
531
531
530
530
Retained Earnings
951
1 551
2 164
2 708
3 271
4 554
7 728
11 439
13 905
16 657
19 984
23 674
28 302
36 894
41 603
52 244
57 918
68 242
71 636
91 480
115 797
126 090
134 120
148 050
Additional Paid In Capital
0
0
0
0
0
572
572
640
965
1 041
1 064
1 064
1 064
1 064
799
799
799
799
799
799
799
799
800
800
Other Equity
0
0
0
0
0
99
185
206
44
12
2
2
2
0
0
0
0
0
134
136
155
251
260
310
Total Equity
1 067
N/A
1 679
+57%
2 292
+37%
2 837
+24%
3 399
+20%
5 354
+58%
8 614
+61%
12 414
+44%
15 178
+22%
17 975
+18%
21 315
+19%
25 006
+17%
29 633
+19%
38 223
+29%
42 933
+12%
53 574
+25%
59 248
+11%
69 572
+17%
73 099
+5%
92 946
+27%
117 282
+26%
127 671
+9%
135 710
+6%
149 690
+10%
Total Liabilities & Equity
2 052
N/A
2 925
+43%
3 834
+31%
4 543
+18%
6 491
+43%
8 436
+30%
11 787
+40%
15 548
+32%
18 660
+20%
22 748
+22%
27 567
+21%
31 388
+14%
37 105
+18%
43 829
+18%
49 021
+12%
61 585
+26%
67 859
+10%
80 383
+18%
85 357
+6%
107 741
+26%
133 747
+24%
144 388
+8%
154 700
+7%
169 320
+9%
Shares Outstanding
Common Shares Outstanding
231
256
256
256
256
258
258
259
264
265
265
265
265
265
265
265
265
265
265
265
265
265
265
265